Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Top Menu

  • Indication Indication

    VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.

  • Important Safety Information
  • Patient Information
  • Full Prescribing Information
  • For Healthcare Professionals
VYNDAMAX (tafamidis) 61mg logo

Top Menu

  • Indication Indication

    VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.

  • Important Safety Information
  • Patient Information
  • Full Prescribing Information
  • For Healthcare Professionals

Main Menu

  • Home
  • About ATTR-CM
    • What is ATTR-CM?
    • ATTR-CM symptoms
  • About VYNDAMAX
    • How VYNDAMAX may help
    • How VYNDAMAX works
    • Talking to your doctor
    • Custom discussion guide
  • Taking VYNDAMAX
    • Starting on VYNDAMAX
    • Staying on VYNDAMAX
    • Dosing and side effects
  • Real Patient Stories
    • Stan’s Story
    • Share your story
  • Savings & Support
    • Financial assistance
    • Patient support & advocacy
    • Educational resources
  • EXPLORE VYNDACARES
  • Indication
  • Important Safety Information
  • Patient Information
  • Full Prescribing Information
  • For Healthcare Professionals
EXPLORE VYNDACARES

Top Menu

  • Indication Indication

    VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.

  • Important Safety Information
  • Patient Information
  • Full Prescribing Information
  • For Healthcare Professionals
VYNDAMAX (tafamidis) 61mg logo

Main Menu

  • Home
  • About ATTR-CM
    • What is ATTR-CM?
    • ATTR-CM symptoms
  • About VYNDAMAX
    • How VYNDAMAX may help
    • How VYNDAMAX works
    • Talking to your doctor
    • Custom discussion guide
  • Taking VYNDAMAX
    • Starting on VYNDAMAX
    • Staying on VYNDAMAX
    • Dosing and side effects
  • Real Patient Stories
    • Stan’s Story
    • Share your story
  • Savings & Support
    • Financial assistance
    • Patient support & advocacy
    • Educational resources
  • EXPLORE VYNDACARES
  • Indication
  • Important Safety Information
  • Patient Information
  • Full Prescribing Information
  • For Healthcare Professionals
EXPLORE VYNDACARES

Before you go, if you ever need to access this tool again you can find it here in Support and Resources

IMPORTANT SAFETY INFORMATION AND INDICATION

View More
Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.
 

IMPORTANT SAFETY INFORMATION AND INDICATION

Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.
 
Pfizer logo in white
Report Adverse Events Terms of Use Privacy Policy Contact Us About Pfizer Site Map
Patients should always ask their doctors for medical advice about adverse events.
You are encouraged to report adverse events related to Pfizer products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.
This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.
© 2024 Pfizer Inc. All rights reserved.
December 2024 PP-VDM-USA-2054

IMPORTANT SAFETY INFORMATION AND INDICATION

View More
Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.

You are now leaving VYNDAMAX.com

Links to other websites are provided as a convenience to the viewer. Pfizer accepts no responsibility for the content of linked sites.

You are now leaving VYNDAMAX.com

The information provided in this website is intended only for healthcare professionals in the United States.

Indication

VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.|t